Development of the human embryo depends on the ability of first trimester cytotrophoblastic stem cells to differentiate and invade the uterus. In this process, transient expression of an invasive phenotype is part of normal cytotrophoblast differentiation. Morphologically, this process begins when polarized chorionic villus cytotrophoblasts form multilayered columns of nonpolarized cells, and invade the uterus. Using immunocytochemistry, we compared the presence of adhesion receptors and extracellular matrix ligands on cytotrophoblasts in villi, cell columns, and the uterine wall. Villus cytotrophoblasts, anchored to basement membrane, stained for alpha 6 and beta 4 integrin subunits and both merosin and A-chaincontaining laminin. Nonpolarized cytotrophoblasts in columns expressed primarily alpha 5 and beta 1 integrin subunits and a fibronectin-rich matrix. Cytotrophoblast clusters in the uterine wall stained for alpha 1, alpha 5, and beta 1 integrins, but not for most extracellular matrix antigens, suggesting that they interact primarily with maternal cells and matrices. Tenascin staining was restricted to stroma at sites of transition in cytotrophoblast morphology, suggesting that tenascin influences cytotrophoblast differentiation. Our results suggest that regulation of adhesion molecule expression contributes to acquisition of an invasive phenotype by cytotrophoblasts and provide a foundation for studying pathological conditions in which insufficient or excessive trophoblast invasion occurs, such as preeclampsia or choriocarcinoma.
Introduction
The process by which an epithelial cell acquires an invasive phenotype is complex and difficult to study in vivo. In the adult, such transitions are usually observed retrospectively, as tumors. During embryonic development, however, certain cells exhibit invasive behavior as a normal part of their differentiation program. The trophoblastic stem cell of the placenta, the cytotrophoblast (CTB)', is one such cell type. CTB are highly migratory and able to invade basement membranes (BM) as well as interstitial matrices. Since the structural organization ofplacental tissue at the fetal-maternal interface recapitulates spatially the differentiation process by which noninvasive CTB stem cells acquire the ability to invade the uterine wall, it is an ideal tissue in which to monitor the molecular changes that take place during acquisition ofan invasive phenotype. Furthermore, errors in either direction in the depth of implantation in humans result in pathologic conditions. Insufficient invasion contributes to the development of preeclampsia (1), a condition that results in fetal intrauterine growth retardation and maternal hypertension and proteinuria (2) . Unrestricted invasion results in a variety ofpremalignant conditions (placenta accreta, hydatidiform mole) as well as choriocarcinoma. Thus, understanding factors regulating CTB invasion is critical to understanding the etiology oftrophoblast-related disorders.
Two CTB differentiation pathways exist, giving rise to trophoblast populations that are morphologically and functionally distinct (3) (4) (5) (6) (7) (8) . In the first trimester, CTB stem cells reside in chorionic villi of two types (Fig. 1, A and B ). "Floating" villi ( Fig. 1, A and B ; FV) do not contact the uterine wall. CTB in these villi exist exclusively as polarized epithelial monolayers, anchored to a BM and surrounding a stromal core containing fetal blood vessels. These CTB, which are highly proliferative in the first trimester of gestation, differentiate exclusively by fusing to form a syncytial layer (STB) that covers the villus. Floating villi, which comprise the fetal compartment ofthe placenta, are bathed by maternal blood and perform gas and nutrient exchange functions for the developing embryo.
In contrast, anchoring villi (Fig. 1, A and B ; AV) contain CTB stem cells that enter both differentiation pathways. In much of the anchoring villus, CTB fuse to form syncytium. However, at selected sites CTB break through the syncytium and form multilayered columns ofnonpolarized cells. Anchoring villi, via these cell columns, physically connect the embryo to the uterine wall and give rise to the most highly invasive and migratory CTB. These cells, also referred to as intermediate trophoblasts (9, 10) , are found in the pregnant endometrium (decidua) and the first third of the myometrium (collectively called the placental bed), and a subpopulation invades uterine blood vessels. The process of anchoring villus formation, and associated CTB invasion ofthe uterine wall, is extremely active Fn, fibronectin; FnA, Fn that includes the EIIIA alternatively spliced domain; FnB, Fn that contains the EIIIB alternatively spliced domain; 1st TM, first trimester; hPL, human placental lactogen; Ln, laminin; Ln A, Ln with standard A chain; Ln M, a Ln with an alternative A chain; Ln B 1, Ln with the standard BI chain; Ln S, s-Ln with an alternative B I chain; Ln B2, the B2 chain of Ln; STB, syncytiotrophoblast; Tn, tenascin. during the first trimester, resulting in rapid placental expansion (10, 1 1). Thus, human CTB differentiation along the invasive pathway is highly unusual in that successful penetration ofthe uterine wall by CTB requires that they transiently express an invasive phenotype similar to that displayed by malignant tumor cells.
Sections of a full-thickness first trimester implantation site ( Fig. 1, B and C) contain the fetal-maternal transition zone, which is comprised of anchoring villi, their associated cell columns and the decidualized endometrium ( Fig. 1 A, zones I-IV; see also references 9, 10) . At the interface of the villus and the cell column (zones I and II), the organization ofCTB changes, from a polarized cell layer anchored on a BM to a multilayered column of coherent, nonpolarized cells. The CTB throughout the length of the column have a similar vacuolated morphology. However, results to be presented below show that column CTB have regional differences with respect to their expression of matrix components and adhesion receptors. Therefore, we have designated a proximal column region, comprised of the first few cell layers (zone II), and a distal column region (zone III). Where columns contact the uterine wall, they spread laterally and penetrate the endometrium (transition from zone III to zone IV). The column structure is then lost, and CTB within zone IV are present as clusters of irregularly shaped cells interspersed among maternal leukocytes and decidual cells of the endometrium (Fig. 1 , A and C). With deeper penetration the CTB clusters consist of fewer cells, and single cells are frequently seen within the myometrium.
The description above indicates that differentiating CTB undergo striking changes in their relationships with one another and with extracellular components ofboth fetal and maternal origin. These morphological changes are likely to involve extensive modulation in CTB expression of adhesion molecules and extracellular matrix (ECM) components. To test this hypothesis, we used an immunocytochemical approach and sections of the fetal-maternal transition region ( Fig. 1 , B and C). Our results document that marked changes in the distribution patterns of adhesion-related molecules accompany the spatial progression of CTB from the chorionic villi to the uterine wall.
Methods

Antibodies
Markersfor cytotrophoblasts. In chorionic villi and the column portion of anchoring villi, cytokeratins are the most useful markers for CTB. Anticytokeratin antibodies stain CTB and STB but not villus stromal components (7) . In contrast, antibody against the hormone human placental lactogen (hPL), which is specific for differentiated trophoblasts, stain only the STB layer that surrounds villi and cell columns and distinguishes this layer from the underlying villus and column CTB (9) . Within the uterine wall anti-hPL is the most useful reagent, as it reacts specifically with the differentiated CTB (also called intermediate trophoblasts) present in the placental bed (9) . In contrast, anticytokeratins stain uterine epithelium as well as CTB. Polyclonal antibody against hPL was obtained from Dako Corp., Carpenteria, CA. MAb (INNhPL-37) against hPL was obtained from Serotec Ltd., Blackthorn Bicester, UK. The rat anticytokeratin MAb 7D3 was produced in this laboratory by injection of first trimester (1st TM) CTB into rats as described previously (12) . Its specificity was identified by the immunofluorescence staining pattern on JAR choriocarcinoma cells and immunoblotting of JAR cell extracts (data not shown).
Antibodies against extracellular matrix components. Antibodies were obtained from the following sources: mouse MAbs specific for the A chains ofLn (4C7 and 1 1D5/C4) and ofmerosin (2G9, 1F9/G6), the Bl chain of Ln (3E5/H2E7), and the B2 chain of Ln (2E8/A I1), Dr. Eva Engvall, La Jolla Cancer Foundation, La Jolla, CA (13, 14) ; mouse MAbs against s-laminin (C4 and C 1), an alternative Ln B I subunit, and against the B2 subunit of Ln (D18), Dr. Joshua Sanes, Washington University, St. Louis, MO (15) ; polyclonal rabbit anti-mouse Ln, Deborah Hall and Louis Reichardt, UCSF, San Francisco, CA; rabbit polyclonal anti-Fn, Collaborative Research, Lexington, MA; mouse anti-Fn MAbs specific for the alternatively spliced A and B type III repeats (IST-9 and BC-1, respectively) and for a site common to all Fns (IST-4), L. Zardi, University of Genova, Italy (16); a second commonsite mouse anti-Fn MAb, Telios Pharmaceuticals, Inc., La Jolla, CA; mouse MAb against collagen type IV (Col IV) (#M785), Dako Corp.; polyclonal anti-Col IV (#AB748), Chemicon Intl. Inc., El Segundo, CA; mouse Mab against collagen type III, Robert Burgeson, Shriner's Hospital, Portland, OR; rabbit anti-Tn, Telios Pharmaceuticals.
Antibodies against adhesion receptors. Table I summarizes the specificities of the integrins examined in this study. Rat MAbs against the integrin (31 (AIIB2) and a5 (BIIG2) subunits were produced in this laboratory (12, 17) . A rat anti-a6 MAb (JIB5) not previously described was produced by the same procedures. Its specificity was verified by reciprocal immunodepletion-immunoprecipitation using J lB5 and the known anti-a6 monoclonal antibody GoH3 (not shown; 18). Other adhesion receptor antibodies were obtained as follows: the GoH3 anti-a6 and 1001 1 anti-a2 MAbs, Dr. Arnoud Sonnenberg, Amsterdam (12, 18, 19 ); a rat MAb against the integrin ,B4 subunit (439-9B), Dr. Steven Kennel, Oak Ridge National Laboratories, Oak Ridge, TN (20); a mouse anti-a3 MAb (VM-2), Dr. Vera Morhenn (21); a mouse antia I MAb, originally designated TS2/7 (22) and available commercially under the name ACT-T-SET, T Cell Sciences, Inc., Cambridge, MA; mouse anti-a4 MAbs (P4C2, P3E3), Elizabeth Wayner (23); fluorochrome-conjugated secondary antibodies that had been absorbed to reduce interspecies cross-reactivity (rhodamineor fluorescein-conjugated goat anti-rat and -mouse, and donkey anti-rabbit), Jackson Im-munoResearch Labs., Inc., West Grove, PA.
Tissue preparation and histology
First TM placental floating villi and placental bed biopsies were obtained immediately after elective terminations and were washed in PBS containing 0.5 mM CaCl2, pH 7.2, to remove excess blood. One fullthickness implantation site from a 10-wk placenta was obtained as a result of a therapeutic hysterectomy. This sample contained the entire transition region between the fetal and maternal compartments. For the sake of clarity, most of the figures in this paper are taken from this sample. However, at least five other samples containing either villi and attached columns, or endometrium and myometrium, were examined and found to show similar staining patterns for all the antibodies used in this study. Most tissue samples were fixed for 30-60 min at 4°C in 3% paraformaldehyde in PBS/CaCl2, then washed in PBS containing 0.1 M glycine to block remaining aldehyde groups. For histology, samples were dehydrated in ethanol and embedded in JB4 resin (Polysciences Inc., Warrington, PA). I-,um sections were stained with hematoxylin/eosin and photographed with a Nikon HFX-IIA.
For immunocytochemistry, paraformaldehyde-fixed and washed samples were embedded in OCT (Miles Scientific Div., Miles Laboratories Inc., Naperville, IL) and frozen in liquid nitrogen (7) . 5-Am sections were cut using an HR cryostat (Slee International Inc., Tiverton, RI). To select the most useful sections, every tenth one was stained with hematoxylin and eosin and areas were located that contained all the stages of CTB differentiation within the same section. These sections had the general structure diagrammed in Fig. 1 and shown histologically in Fig. 2 . Neighboring sections were then stained by single or double indirect immunofluorescence to locate both an adhesion molecule and a CTB marker antigen. Unless otherwise indicated, all antibodies were incubated with sections of tissue prepared in this way. A few samples were frozen immediately without prior fixation, and frozen II. ) with an associated cell column, and the uterine wall. The spatial organization of this tissue (as indicated by demarcation into zones) recapitulates the differentiation of cytotrophoblasts (CTB) along the invasive pathway. Most of zone I has the structure of a floating chorionic villus: mononuclear CTB stem cells, separated from the stromal core (S) by a basement membrane (BM), fuse to form the overlying syncytiotrophoblast (STB) layer. However, at discrete sites in anchoring villi, CTB form a cell column that connects the fetal and maternal compartments of the placenta (zones II and III). The column spreads laterally in regions of contact with the uterine wall, and there is shallow penetration (this begins zone IV). The column then breaks up into clusters of CTB which penetrate the decidual layer and superficial myometrium (MY). The expression of adhesion and matrix components in these four zones is described in Results and summarized in Table  II sections were fixed with absolute methanol at -20'C before incubation with antibodies. No significant differences were found between fixed and directly frozen tissues in the staining patterns of the antibodies used for this study. However, the morphology of the paraformaldehyde-fixed material was superior.
Culture andfixation ofisolated CTB
Cytotrophoblasts were isolated from 1st TM chorionic villi as described previously (7, 24) . Cells were plated (5 X I05/l 5-mm diameter well) in Dulbecco's minimal essential medium containing 20% fetal bovine serum and 50 Ag/ml gentamycin for 12-18 h on 11 -mm glass cover slips that had been coated for 2 h with a thin layer of Matrigel (Collaborative Research) or with a mixture of Ln, Col IV, and Fn (10 ,ug/ml each, Collaborative Research). Under these conditions, CTB form aggregates ofpartially spread cells. Cells were rinsed with PBS and fixed in absolute methanol for 5 min at -20°C, then air dried.
Immunocytochemistry
Frozen tissue sections or cover slips with permeabilized cells were rinsed in PBS containing 1 mM CaCI2 and MgCi2, and nonspecific staining was blocked by incubating samples with 0.2% BSA in PBS (PBS-BSA). Samples were then exposed for 1-2 h to individual primary antibodies or to a mixture oftwo primary antibodies ofdifferent species origin, diluted in PBS. Samples were washed with several changes of PBS-BSA for 15 min, incubated for 30 min with the appropriate secondary antibodies conjugated to either rhodamine isothiocyanate or fluorescein isothiocyanate, rinsed in several changes of PBS, and mounted using Gelvatol (Air Products & Chemicals, Inc., Allentown, PA), which contained p-phenylenediamine (Sigma Chemical Co., St. Louis, MO) to inhibit quenching of the fluorescein signal. Normal or nonrelevant rabbit, rat, or mouse IgG were substituted for primary antibodies as controls for nonspecific staining. The staining patterns ofmost antibodies were tested on at least five different tissue samples. No antibody was evaluated on fewer than three samples. Samples were examined with a Zeiss phase/epifluorescence microscope equipped with the appropriate filters and a x63 planapo oil immersion objective. Sections were photographed with Kodak Tri X film, which was developed with Acufine (Acufine, Inc., Chicago, IL).
Results
Villus CTB are anchored to a complex BM and express primarily the a6/1#4 integrin. The distribution patterns of ECM components and integrin receptors are considered together for each zone in the presentation and discussion ofthe results, which are summarized in Table II . In the villus compartment (zone I), CTB exist as a polarized epithelial monolayer anchored to the trophoblast BM. This BM was unusual in that all the known isoforms oflaminin (Ln) were detected: the LnB2 chain; merosin ( Fig. 2 A) as well as the related Ln A chain (not shown); and s-laminin as well as the related Ln B1 chain (not shown; see also 14) . In addition to the strong basement membrane localization of the Ln subunits detected by all the subunit antibodies, one of the anti-Ln B2 antibodies (D 18) also stained the lateral and apical surfaces of villus CTB in a punctate pattern (Fig. 2  B) . In the villus stroma Ln B2 staining was strong, particularly around blood vessels. The other Ln subunits were detected at much lower levels in the stroma, with staining for merosin (Fig.  2 A) and Ln B 1 more prominent than that for Ln A and s-laminin. Fibronectin (Fn; Fig. 2 C) and Col IV (not shown) were present throughout the villus stroma and in the villus BM.
Staining for both was strong in the stroma, but Fn staining of the trophoblast BM was weak, while that ofCol IV was intense. Examination of Fn isoforms with domain-specific MAbs demonstrated that the Fn present contained both the A and B alternatively spliced regions.
CTB in zone I expressed a limited repertoire of integrin ECM receptors, typical of many polarized epithelia (e.g., the basal layer of the skin; 25, 26) . In particular, staining of villus CTB for the a6 integrin subunit was strong and enriched basally ( Fig. 3 A) . The a6 subunit can associate with the integrin 134 subunit as well as with 31 (27) . A very low level of uniform 131 staining was observed on the CTB cell surface, in addition to the prominent stromal staining (Fig. 3 B) . In contrast, anti-14 ( Fig. 3 C) stained the whole CTB cell surface and, like anti-a6 staining, was enriched basally. This suggests that a6/14 was the major a6-containing complex expressed by villus CTB. The a3 integrin, which, in association with 131, can act as a receptor for Ln, Fn, or Col, stained CTB in 30-40% of villi weakly and uniformly ( Fig. 3 D) . Staining for a 1/131, a Ln and Col receptor, was restricted to the villus stroma and was not detected on villus CTB (Fig. 3 E) . The a5 subunit, which when combined with 1 1 is a Fn receptor, was barely detectable or not detected on villus CTB or the trophoblast BM, but was present on cells and vessels throughout the villus stroma (Fig. 3 F) . Thus, CTB in the villus compartment expressed primarily basally distributed a6/134, and were in association with a complex Lnand Col IV-rich BM. CTB columns are sites of extensive modulation of ECM components and integrin receptors, resulting in distal column CTB with a Fn-rich ECM and high levels of the aS/fl] Fn receptor. In the cell columns (zones II and III), CTB are no longer associated with the trophoblast BM and display a nonpolarized phenotype. These changes in their cytoarchitecture are accompanied by striking alterations in their staining patterns for ECM molecules and integrin receptors. In the proximal portion ofthe CTB columns (zone II), Fn and Col IV were not detected. Surprisingly, the spatial distribution of individual Ln subunits differed in this region. Merosin (Fig. 4 A) and s-laminin (not shown) were not detected on column CTB, whereas the B 1 subunits (not shown) and Ln B2 ( Fig. 4 B) were present. Two antibodies against each subunit were used, and gave the same results. In contrast, Ln A was detected by the choring villi are shown. The stroma is separated from the overlying CTB layer by a basement membrane. A column (COL) emanating from an anchoring villus is shown spreading over the endometrial surface and penetrating the superficial decidua (DEC). (C) A section deeper in the decidual layer showing a small cluster of CTB (arrow) near a maternal blood vessel. Figure 2 . Frozen sections of first trimester floating villus stained for Ln and Fn. In this and all subsequent figures, unless otherwise indicated by use of the specific antibody identification number, all antibodies that recognize a particular antigen gave the same staining pattern. (A) Antimerosin (Ln M) stained the trophoblast basement membrane (BM), the villus stroma (S), and the fetal blood vessels (BV). Antibodies specific for the Ln A, Ln B l, and s-laminin subunits showed a similar staining pattern, although stroma and blood vessel staining was much weaker. (B) Both of the anti-Ln B2 MAbs stained trophoblast BM and fetal blood vessels strongly. In addition, the Ln B2 MAb D18 stained the lateral borders ofthe CTB in a punctate pattern. (C) Staining pattern ofan antibody specific for the EIIIA alternatively spliced domain of Fn. Staining was strong throughout the villus stroma (S), including fetal blood vessels (BV). Weaker staining was also evident on the BM (arrow). Similar patterns were observed with antibodies specific for the EIIIB alternatively spliced domain and for two different sites common to all forms of Fn. 1 1D5/C4 monoclonal antibody, but not by the 4C7 monoclonal antibody (not shown), even though both ofthese antibodies stained the trophoblast basement membrane in floating villi. Thus, the presence of Ln A on column CTB is not clear cut at present and must wait further investigation. The staining patterns of all the anti-Ln-subunit antibodies were the same on both paraformaldehyde-fixed and frozen, methanol-fixed samples (not shown). Thus the absence of staining for merosin or s-laminin in the column region of the tissue, as well as the ambiguity in the Ln A staining, was not likely to be due to the masking ofa particular epitope, or to inactivation ofan epitope by aldehyde fixation. The a3 integrin subunit, present on some villus CTB, was no longer detected in the proximal column (not shown) and remained undetected on CTB in subsequent zones (Table II) . Staining for the a6 and ,B4 subunits continued to be strong in zone II, while a5 and ,B1 were barely detectable (Table II) .
In the distal portion of the column (zone III), several distinct changes in matrix and adhesion molecule staining patterns were evident, although the morphology of the cells did not change dramatically (Figs. 4-5). First, there was a sharp increase in the level of staining of both A+B+Fn and Col IV ( Fig. 4, Cand D) . These ECM components were likely made by the CTB, as there are no other cell types in columns. Further- more, isolated chorionic villus CTB cultured for 12-18 h stained strongly for both A+B+ Fn and Col IV, indicating their ability to synthesize these molecules (not shown). Staining for the a5 and ,31 subunits of the Fn receptor was also strongly enhanced in the distal column (Fig. 5, A and B) . No a3 or a4 was detected on column CTB (not shown). Thus a5//31 is probably the major integrin Fn receptor expressed in this region.
Finally, staining of both the a6 and ,B4 subunits on CTB, while strong in the proximal column, decreased over the remainder of the column (Fig. 5, C and D) to undetectable levels on CTB that were present in the superficial decidua (Table II) . The observation that the distribution patterns of the a6 and ,B4 subunits were very similar and distinct from that of /31 suggested that a6/#4 was the predominant a6-containing complex ex- pressed by CTB in villi and in cell columns, although this does not rule out the presence of some functional a6/3 1, especially in the distal column where #3I staining is strong. Taken together, our data suggest that the transition of CTB from the fetal toward the maternal compartment (zones I to III) is marked most notably by a switch in their pattern of integrin expression from a6/134 to a5/131, and by their synthesis of an extracellular matrix rich in A+B+Fn as well as Col IV, Ln Bl and B2, and perhaps Ln A. In theplacental bed, CTB column structure is lost and stainingpatterns suggest that clusters ofCTB interact primarily with maternal matrix, via al/l3 and a5/13 integrins. Within the placental bed (endometrium and myometrium; zone IV) the column structure was lost, and CTB were present as clusters of irregularly shaped cells or as single cells. Placental bed CTB stained for the hormone hPL, a specific marker for differentiated trophoblasts. These CTB appeared to produce a very restricted matrix of their own. Merosin (Fig. 6 A) , Ln A (not shown), and s-laminin (not shown) were all undetectable on hPL-positive CTB. Staining for Ln B2 using the D 18 MAb (Fig.  6 C) continued to be strong on CTB. However, the Ln B2 MAb 2E8/A 11 did not stain CTB in the placental bed, although it, like the Dl 8 Ln B2 MAb, stained maternal cells. Staining for Ln B1 on CTB was weak and variable (not shown). Placental bed CTB also no longer expressed detectable levels ofFn (Fig. 6 E) or Col IV (not shown) on their cell surfaces. In contrast, the surrounding endometrium and myometrium were rich in Fn (A+B+), Col IV, and Ln A, B 1, and B2 (Fig. 6 , Table II ; see also 28) . Thus, within the placental bed, CTB are likely to interact primarily with a matrix associated with maternal cells. CTB displayed yet another distinct repertoire of 11 integrins within the placental bed ( Fig. 7) : a I/131 ( Fig. 7 A) , not detected on CTB in any other location, and a5/#l (Fig. 7 C) . Other ,1 integrins (a2, a3, a4, a6 [ Fig. 7 El) as well as 134 were not detected on CTB in the placental bed compartment. The presence on CTB ofthis combination of 1 I integrin subunits theoretically gives them the ability to recognize Lns and Col IV (using a 1/,B1) and Fn (using a5/13 1).
Tenascin is expressed in the fetal and maternal stroma at transition points in CTB differentiation. One ofthe most significant potential regulatory points for CTB differentiation occurs when CTB at specific sites in anchoring villi form multilayered cell columns (Fig. 1, A and B) . The signals that trigger this transition and the accompanying changes in adhesion protein expression are unknown. One possible clue was suggested by the distribution pattern ofthe high molecular weight, developmentally regulated ECM component tenascin (Tn). In floating villi, staining for Tn was absent from the stroma beneath the cytokeratin-positive trophoblast layer (Fig. 8, A and B ). In contrast, in the anchoring villus, strong staining for Tn was detected in the stroma immediately subjacent to sites of CTB column initiation (Fig. 8 C) . Tn was not detected on villus CTB. Thus, the Tn distribution was intriguing, as it was the only component detected that distinguished the stromal ECM in the precise region of the anchoring villus where a column formed. Tn was not detected on cytokeratin-positive CTB in columns or in the placental bed. However, it displayed a patchy distribution pattern in the ECM associated with the decidua. Tn also stained discrete arcs at the periphery of some maternal blood vessels, and stained the myometrium strongly and uniformly ( Fig. 8 E) . These results indicate that Tn is expressed selectively at stromal sites where transitions in CTB differentiation take place (initiation sites for column formation; decidua, myometrium, and blood vessels of the uterine wall).
Discussion
Our data represent a comprehensive analysis of the striking changes in the distribution patterns of adhesion receptors and matrix components that take place on CTB in the region of transition between the fetal and maternal compartments ofthe first trimester placenta. This region recapitulates spatially the differentiation process during which polarized CTB monolayers in anchoring villi first become cohesive, nonpolar cell aggregates and then invade the uterine wall as dispersed cell clusters and single cells (5, 8, 9) . Since a great deal of information exists on the function of the adhesion and matrix molecules we have localized, analyzing the specific repertoire of these molecules present at each stage of CTB differentiation provides insight into the concomitant alterations in CTB behavior.
The polarized CTB epithelium of chorionic villi (zone I) is anchored to the trophoblast BM, which contains several isoforms of Ln (see also 14) , A+B+Fn, and Col IV (Table II) . Because oftheir similar staining intensities and basal location, a6 in association with ,34 appears to be the most important receptor complex mediating CTB interactions with the trophoblast BM. The ligand for a6/l34 in BM is unclear, but may be a form of Ln (29) . Other reports document its association with hemidesmosomes (25, 30) . Since weak staining for f31 is detected in the trophoblast BM, it is possible that a small amount of a6/# I may also be present. This should promote CTB interactions with the long arm of Ln in the trophoblast BM (12, 19) .
CTB differentiation along the invasive pathway is initiated at discrete sites in anchoring villi, as evidenced by the presence ofmultilayered cell columns in which CTB are no longer polarized. There was no apparent change in the staining patterns of Ln, Fn, or Col IV associated with the trophoblast BM at sites of column initiation. However, Tn was detected in the villus stroma under the BM only at sites of column formation. The nature of Tn's contribution is suggested by its well-documented transient induction in mesenchyme by epithelium, during epithelial-mesenchymal interactions (reviewed in 31, 32) . It is possible that during column formation an analogous signalling process is triggered at or near villus tips in anchoring Anti-(B4 staining in the placental bed was restricted to the UE basement membrane (not shown). Thus, a6 in the endometrium and myometrium is associated with #Bl. villi, causing stromal cells to produce Tn, which then promotes disorganization of the overlying polarized CTB monolayer. This would permit the formation of a cohesive, multilayered column of CTB.
CTB displayed altered patterns of expression of several adhesion and matrix components, both at the outset of column formation (zone II, proximal column) and along the length of the column (zone III, distal column). Fn and the a5 and #1 subunits of the a5/l#l Fn receptor were not detected in the first few layers of the column (zone II). However, staining for all three increased substantially in the distal column. In light of the observation that staining for the a6 and (4 subunits was reduced in that area, these data suggest that a5/l31 interaction with A+B+ Fn of CTB origin is the major CTB-matrix interaction exhibited in zone III. The remaining a6/(34 and/or a6 in association with ,31 may also interact with Ln, or with other ECM components present in this region.
Within the placental bed, CTB appeared to lack a cell-asso- (33, 34) . Immunocytochemistry with additional subunit-specific antibodies, in situ hybridization, and a careful search for alter-native Ln isoforms will be required to settle the issue of what kind ofLn, ifany, is being made by first trimester placental bed CTB. Placental bed CTB also displayed a distinctive repertoire of integrins: 131, but not 34, was detected, and the a subunit repertoire was restricted to the a 1 and a5 subunits. Thus the predominant interactions ofCTB in the placental bed are likely to involve CTB a 1/,13 and a5/fl31 with maternal cell-associated ECM, which is rich in Col IV, Ln, and Fn (28), as well as Tn (Fig. 8 ).
The striking changes in the repertoire ofadhesion receptors detected on differentiated placental bed CTB, combined with exposure to the distinctive maternal ECM, are likely to affect the behavior and gene expression of CTB. For example, by changing their repertoire of Ln receptors (see Tables I and II) , villus CTB and differentiated placental bed CTB might interact with structurally distinct regions ofLn (35) , resulting in distinct cellular responses. In support of this idea are our observations that in JAR choriocarcinoma cells, the a 1/,1( integrin recognizes a site in the cross region of Ln (12; see also 36) whereas a6/1 recognizes a site in the structurally distinct Ln long arm (12, 19) . In a second example, the presence of Tn at sites of column formation and in the decidual/myometrial ECM may also influence CTB motility and invasiveness. As discussed above, Tn expression at selected sites in the villus stroma may play a role in CTB column formation. Data showing that addition of Tn to Fn substrates in vitro reduces cell adhesiveness to Fn (37) and mimics the ability of Fn fragments and anti-Fn receptor antibodies to induce metalloproteinase expression in fibroblasts (38) support the idea that Tn could influence cell motility and invasion. Such matrix-induced effects on motility and proteinase expression are likely to be particularly relevant to the transient tumor cell-like behavior of 1st TM CTB (24) .
The alterations in distribution patterns of adhesion and matrix molecules on CTB in cell columns and within the uterine wall in vivo fit into a larger picture of CTB differentiation that includes hormones, proteinases, and proteinase inhibitors (24, 39) . Our studies to determine the role ofthose components have resulted in the development ofan in vitro model in which 1st TM CTB, but not late gestation CTB, aggregate and invade Matrigel. Studies using this model have revealed a critical role for the 92-kD type IV collagenase in CTB invasion (24) . Preliminary results indicate that CTB which are invading Matrigel exhibit a repertoire ofmatrix and adhesion components similar to that reported here for differentiating CTB in vivo (Fitzgerald, M. L., and C. H. Damsky, unpublished experiments). Therefore this model, in conjunction with function-perturbing antibodies against the adhesion molecules that we have now shown to be differentially expressed during CTB differentiation in vivo, will be extremely useful in determining the functional role of these components in trophoblast invasion. These studies also lay the foundation for determining whether abnormal regulation of adhesion or matrix molecule expression is a feature of placental disorders involving insufficient or excessive invasion.
